Abstract
WE have compared chemotherapy and immunotherapy in AKR mice injected with a syngeneic tumour, strain BW5147 lymphatic leukaemia. Previous investigations disclosed significant therapeutic benefit from isologous or homologous antiserum against mouse leukaemia1–4 or with antiserum raised against murine tumour viruses5. In contrast, toxicity has been a significant obstacle to the therapeutic use of heterologous antiserum6,7. Reports8–12 of successful use of heterologous antiserum, however, suggested that further study was warranted, and an experiment was designed to compare quantitatively the therapeutic activity of antiserum with conventional chemotherapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gorer, P. A., J. Pathol. Bact., 54, 51 (1942).
Werder, A. A., Kirschbaum, A., MacDowell, E. C., and Syverton, J. T., Cancer Res., 12, 886 (1952).
Amos, D. B., and Day, E. D., Ann. NY Acad. Sci., 64, 851 (1956).
Mihich, E., Cancer Res., 29, 848 (1969).
Chirigos, M. A., March, R. W., Hook, W., and Hoemann, R., Proc. Soc. Exp. Biol. Med., 125, 35 (1967).
Levi, E., Golden, R., Zerubavel, R., and Fisher, J., Cancer Res., 26, 659 (1966).
Thompson, J., Blood, 10, 1228 (1955).
Nungester, W. J., and Fisher, H., Cancer Res., 14, 284 (1954).
Mohos, S. C., and Kidd, J. G., J. Exp. Med., 105, 233 (1957).
Alexander, P., Connell, D. I., and Mikulska, A. B., Cancer Res., 26, 1508 (1966).
Guthrie, R. K., Ingerbrigtsen, N. A., Savage, N., Hinkle, D. C., and Farris, W. J., Canad. J. Biochem., 41, 305 (1963).
Reif, A. E., and Kim, C. H., Proc. Amer. Assoc. Cancer Res., 10, 72 (1969).
Parks, S. D., and Hill, G. J., Current Topics in Surgical Research, 2, 247 (1970).
Skipper, H. E., Schabel, jun., F. M., and Wilcox, W. S., Cancer Chemother. Rep., 35, 1 (1964).
Lane, M., J. Nat. Cancer Inst., 23, 1347 (1959).
Hill, G. J., Atkins, R. C., Parks, S. D., Littlejohn, K., and Eiseman, B., Surg. Forum, 20, 122 (1969).
Miller, D. G., Moldovanu, G., Kaplan, A., and Tocci, S., Cancer, 22, 1192 (1968).
Mardiney, jun., M. R., Block, J. R., and Serpick, A. A., Cancer Chemother. Rep., 53, 3 (1969).
Monaco, A. P., Wood, M. L., Gray, J. G., and Russell, P. S., J. Immunol., 96, 229 (1966).
Iwasaki, Y., Porter, K. A., Amend, J. R., Marchioro, T. L., Zuhlke, V., and Starzl, T. E., Surg. Gynec. Obstet., 124, 1 (1967).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
HILL, G. Treatment of Murine Leukaemia with Heterologous Antiserum or Cyclophosphamide. Nature 232, 196–197 (1971). https://doi.org/10.1038/232196a0
Received:
Revised:
Issue date:
DOI: https://doi.org/10.1038/232196a0